Infliximab Antibody Test in Dubai & UAE | Monitor Drug Efficacy | Accredited Lab
Detect anti-drug antibodies to optimize your biologic treatment for Crohn’s, Ulcerative Colitis, and Rheumatoid Arthritis. Performed at our ISO 17025 accredited Dubai laboratory, ensure your therapy remains effective.
What is the Infliximab (Anti-Drug Antibody) Test?
The Infliximab Antibody Test is a specialized blood test that measures the level of antibodies your immune system may have developed against the biologic drug Infliximab (brand names include Remicade®, Inflectra®, Remsima®).
When your body produces these anti-drug antibodies (ADAs), they can bind to the medication, neutralizing its effect and increasing the risk of reduced response, loss of remission, or infusion reactions. This test is often paired with a trough level check to measure the actual amount of active drug in your bloodstream before your next dose.
Why is This Test Critical for Patients in the UAE?
For patients in Dubai and the UAE managing chronic inflammatory conditions, biologic drugs like Infliximab are essential for maintaining quality of life. However, studies show a significant number of patients develop antibodies over time. This test provides actionable data for your specialist to:
- Explain a loss of response or disease flare-up.
- Guide a change in therapy (dose increase, interval shortening, or switch to another biologic).
- Prevent unnecessary continuation of an ineffective treatment.
- Investigate suspected infusion-related reactions.
Why Choose DNA Labs UAE for Your Biologic Drug Monitoring?
| Feature | DNA Labs UAE (Dubai) | Typical Alternatives |
|---|---|---|
| Laboratory & Accreditation | ISO 17025 Accredited Lab in Dubai. Local analysis ensures stability of sensitive samples. | Often sent abroad, increasing transit time and potential sample degradation. |
| Reporting Time | Fast, local turnaround. Receive precise results quickly to inform urgent treatment decisions. | Delayed results due to international shipping and processing. |
| Expertise | Specialized in advanced pharmacogenomic and immunology testing. | General laboratories may lack specific interpretive expertise. |
| Clinical Guidance | Results formatted for clear clinical interpretation in consultation with your treating specialist. | Basic numerical reporting without contextual guidance. |
Our Promise: Accurate, timely results from our ISO accredited Dubai laboratory to empower you and your doctor with confidence.
View our official accreditation: ISO Certificate
Who Should Get Tested? Key Indications
Your gastroenterologist or rheumatologist may recommend this test if you are on Infliximab and experience:
- Loss of Response: Symptoms flare up despite ongoing treatment.
- Suboptimal Therapeutic Drug Levels: A routine trough level test shows low circulating drug.
- Suspected Immunogenicity: Before switching or dose intensification to guide the decision.
- Infusion Reactions: Experiencing reactions during or after drug administration.
The Testing Process: Simple & Streamlined
1. Get a Referral
Obtain a test request form from your treating specialist (Gastroenterologist or Rheumatologist). We require this medical referral to ensure appropriate testing and reporting.
2. Visit Our Dubai Lab
Visit our patient collection center in Dubai at your convenience. No appointment is typically needed. We follow strict protocols for sample handling.
3. Blood Sample Collection
A small blood sample is drawn by our professional phlebotomist. The sample is processed and analyzed in our on-site accredited laboratory.
4. Receive Your Detailed Report
Your specialist will receive a comprehensive report detailing:
- Anti-Infliximab Antibody Level: (Positive/Negative with concentration).
- Infliximab Trough Level: (The amount of active drug in your system).
- Clinical Interpretation: To aid in therapeutic decision-making.
For patients investigating genetic factors in drug metabolism or disease, explore our Pharmacogenomics Testing services.
Pricing Information
The Infliximab Antibody Test is priced at AED 850.
- Combined Test (Antibody + Trough Level): AED 1,200 (Recommended for full clinical picture).
- Venue-based / Home Collection: Available across the UAE for an additional fee. Please contact us for a quote.
*Prices are inclusive of VAT. Results are typically available within 5-7 business days.*
Frequently Asked Questions (FAQ)
Q: How should I time this test with my infusion?
A: The blood draw should be performed immediately before your next scheduled Infliximab infusion (at the “trough” level). This timing gives the most accurate picture of your drug and antibody levels.
Q: What does a positive antibody result mean?
A: A positive result indicates your immune system has developed antibodies against the drug. This often leads to faster drug clearance, lower effective drug levels, and can cause a loss of response or reactions. Your doctor will use this result, along with your trough level and clinical status, to decide on the best management strategy.
Q: If I test positive for antibodies, can I ever use Infliximab again?
A: Management is personalized. Options may include increasing the dose, shortening the interval between infusions, or adding an immunomodulator. In many cases, a switch to a different biologic drug (often within the same or a different class) is the most effective strategy.
Q: Is this test covered by insurance in the UAE?
A: Many major health insurance providers in Dubai and the UAE cover this test when it is medically requested by a specialist with a proper referral. We recommend checking with your provider and can assist with pre-authorization if required.
Q: Why is your local Dubai lab accreditation important?
A: ISO 17025 accreditation is the international benchmark for technical competence in testing. For sensitive biologic drug monitoring, it guarantees the analysis is performed under the highest standards of quality, precision, and traceability, ensuring you can trust the result for critical health decisions.
DNA Labs UAE | Accredited Laboratory in Dubai
Precision Testing for Personalized Treatment.
